Statistics
Publications
1
Citations
16
H-Index
1
Active since
2023
Affiliations
Institute of Pharmacology(Current)
Martin Lukás is an author at Institute of Pharmacology specializing in immunotherapy, crohn disease pharmacotherapy, and gastrointestinal inflammation.
Publications per year
2023–2023
1
1
Subcutaneous Infliximab in Refractory Crohn’s Disease Patients: A Possible Biobetter?
Karin Černá, Dana Ďuricová, Martin Lukás et al. · Crohn s & Colitis 360 · 2023 · 16 citations · Full text
1–1 of 1